Researchers only, not for human or animal consumption · 21+ only
Analytical Testing

Peptide Identity Testing: HPLC Retention Time vs Mass Spectrometry

How labs confirm a peptide is the labeled compound: HPLC retention-time matching vs LC-MS or MALDI mass confirmation, and what each method can miss.

Published 2026-11-09. By Elevate Research Labs. · 5 min read

An identity line on a certificate of analysis answers one question: is the main component in this sample the compound named on the label? Why that question is separate from purity is covered in HPLC purity vs. identity. This article is about the next question: how a laboratory establishes identity, and what each common method can and cannot tell apart.

What an identity test is expected to prove

The international guideline on validating analytical methods, ICH Q2(R2), sets out what an identification test has to show. It should give a positive result comparable to a reference material when the analyte is present, a negative result when it is absent, and it should be challenged with materials structurally similar or closely related to the analyte to confirm they do not also pass. The same guideline recommends combining two or more procedures where one alone does not discriminate well enough.

That last point is the useful lens. No identity method is perfect. The question for any certificate is which lookalikes its method would catch, and which it would wave through.

Method 1: HPLC retention-time matching (HPLC-RTM)

In retention-time matching, the laboratory runs a reference standard, a sample of the target compound whose identity has already been established, through the HPLC system, and then runs the test sample under the same conditions. Each compound leaves the column at a characteristic time. If the sample's main peak appears where the standard's peak does, identity is confirmed by that method.

Strengths. It compares the sample directly against authentic material, and it uses the same kind of chromatographic run that produces the purity figure. A wrong compound with a different structure will usually travel through the column at a different speed and miss the match.

Limits.

  • Retention time is not unique. Two different molecules can leave the column at the same time. An FDA laboratory study of peptide quality control described a synthetic peptide product containing both an amino-acid deletion and an amino-acid insertion that the submitted HPLC-UV methods could not resolve. If an impostor or impurity co-elutes with the target, a retention-time match cannot see it.
  • It needs an authentic standard. The match is only as good as the standard behind it. If the reference material is wrong, or of unknown provenance, a perfect match proves only that sample and standard agree with each other.
  • It depends on conditions. Retention time shifts with the column, mobile phase and settings, which is why the standard and sample must be run under the same conditions for the comparison to mean anything.

Method 2: mass spectrometry (LC-MS and MALDI)

Mass spectrometry measures the mass-to-charge ratio of ions made from the sample. For a synthetic peptide with a known sequence, the expected mass can be calculated in advance, so the measured value can be checked against theory as well as against a standard.

Two set-ups are common:

  • LC-MS puts a mass spectrometer after the chromatography column, so each peak gets a mass as well as a retention time. A Waters application note shows intact-mass LC-MS confirming that the intended peptide was made, and assigning impurities such as oxidation, deamidation and loss of a methionine residue by their mass, each within 10 ppm mass error.
  • MALDI, usually paired with a time-of-flight analyzer, mixes the sample with an energy-absorbing matrix and ionizes it with a laser pulse. The flight time to the detector gives the mass-to-charge ratio. Shimadzu's primer describes it as a powerful tool for peptides and proteins.

What mass catches. Changes to a peptide's sequence, including truncation, insertion, substitution and deletion, typically produce detectable mass shifts. A deletion sequence missing one residue weighs less by that residue's mass, even if it co-elutes perfectly with the target. This is the failure mode retention time misses, and it is where mass spectrometry is strongest.

What mass cannot catch on its own. Any variant with the same elemental formula has the same mass:

  • Isomeric residues. Leucine and isoleucine share a formula, so swapping one for the other leaves the mass unchanged.
  • Rearranged sequences. The same residues in a different order add up to the same mass.
  • Isomerization during synthesis. Aspartic acid can convert to isoaspartic acid as a byproduct of peptide synthesis. The two forms have the same mass, and even their fragments in standard tandem MS remain isobaric and ambiguous. Telling them apart takes extra separation, such as ion mobility.

A single intact-mass number therefore rules out the wrong weight. It does not by itself rule out the wrong arrangement.

Why some certificates show both

The two methods fail in different places. Retention time can be fooled by a co-eluting molecule of a different mass, and mass can be fooled by an isomer. An isomer that separates on the column fails the retention-time match, and a co-eluting deletion fails the mass check. Reporting both is the "combination of two or more procedures" approach ICH Q2(R2) recommends. It is still not complete: an isomer that co-elutes and shares the mass needs tandem MS, ion mobility or sequencing to resolve. But each method closes a gap the other leaves open.

Our certificates: HPLC-RTM, not mass spectrometry

On our published certificates, from ILS Laboratories, identity is established by retention-time matching. The line reads Identity (HPLC-RTM), with a specification such as BPC-157 Confirmed and the result Confirmed. We do not currently report mass-spectrometry identity, and we would rather say so than leave you to assume it.

In practice, that line tells you the main peak matched the laboratory's reference standard under the same chromatographic conditions. It does not give a measured molecular mass, and like any retention-time method it cannot exclude a co-eluting species of different mass. The certificate also does not name the reference standard's source. Sixteen of our seventeen current certificates carry the identity line. The CJC-1295 + Ipamorelin blend certificate does not include one.

If your work depends on a confirmed molecular mass, the honest answer is to commission mass confirmation from an independent laboratory, whatever the supplier. Whichever method a certificate uses, check that the laboratory's own record matches it. Enter the access code at ils-lab.com/verify, or follow the steps in how to verify a COA with the issuing laboratory. For a line-by-line read of one of our identity results, see the BPC-157 certificate walkthrough.

For laboratory research use only — not for human or veterinary use.

Sources & further reading

  1. ICH Q2(R2) Validation of Analytical Procedures (2023)
  2. Zeng et al., Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control (AAPS J, 2015; FDA authors)
  3. Cyclic ion mobility mass spectrometry for aspartic-acid isomers in peptides (J. Am. Soc. Mass Spectrom., 2022)
  4. Streamlined LC-MS Analysis of Stress Induced Impurities of a Synthetic Peptide (Waters application note)
  5. MALDI Theory and Basics (Shimadzu)
  6. ILS Laboratories certificate verification
Referenced materials

BPC-157 · CJC-1295 + Ipamorelin Blend

BPC-157 certificate of analysis · CJC-1295 + Ipamorelin Blend certificate of analysis

All materials are for in-vitro laboratory research use only — not for human or veterinary use.

Related reading